Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SB010 Phase 2a in Mild Allergic Asthma
NCT01743768Phase 2Completed
- Sponsor
- sterna biologicals
- Start
- Dec 2012
- Primary completion
- Nov 2013
- Modality
- Modified DNA Oligonucleotides, Single-strand DNA, Antisense Oligonucleotides (ASOs)
- Countries
- 1
01
Overview
A Phase 2 trial of SB010 in asthma, sponsored by sterna biologicals. Started Dec 2012; status: completed.
02
Drugs
SB010
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01743768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01743768.